# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

B-Cell Lymphomas

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 41-50 of 2194 results.
A Study of MIL62 Combined With ICP-022 for the Treatment of R/R CD20+B Cell Lymphoma
Status: Not yet recruiting
Last Changed: Jun 17, 2020
First Received: Mar 11, 2020
Disease(s): B-cell Lymphoma Recurrent, B-cell Lymphoma Refractory
Intervention(s): ICP-022, Recombinant humanized monoclonal antibody MIL62 injection
Locations: Beijing Hospital, Beijing, Beijing, China
Beijing Shijitan hospital, capital medical university, Beijing, Beijing, China
Cancer hospital, Chinese academy of medical sciences, Beijing, Beijing, China
Study of Anti-CD22 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma
Status: Not yet recruiting
Last Changed: Jan 30, 2019
First Received: Oct 02, 2018
Disease(s): Refractory B-Cell Lymphoma
Intervention(s): Anti-CD22 CAR NK Cells
Study of Anti-CD19 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma
Status: Not yet recruiting
Last Changed: Jan 31, 2019
First Received: Oct 01, 2018
Disease(s): Refractory B-Cell Lymphoma
Intervention(s): Anti-CD19 CAR NK Cells
Copanlisib With Rituximab-Bendamustine in Patients With Relapsed-Refractory Diffuse Large B-cell Lymphoma
Status: Not yet recruiting
Last Changed: Jun 16, 2020
First Received: Jun 16, 2020
Disease(s): Diffuse Large B-cell Lymphoma
Intervention(s): Copanlisib
Locations: Ospedale Monsignor Raffaele Dimiccoli - Ematologia, Barletta, Barletta-Andria-Trani, Italy
Istituto Clinico Humanitas - U.O. Ematologia, Rozzano, Milano, Italy
Centro Riferimento Oncologico - S.O.C. Oncologia Medica A, Aviano, Pordenone, Italy
IRCCS-Centro di Riferimento Oncologico - UO di Ematologia e Trapianto Cellule Staminali, Rionero In Vulture, Potenza, Italy
Ospedale Dell'Angelo - U.O. Ematologia, Mestre, Venezia, Italy
... and 25 other locations.
Feasibility Study Of Adding Bortezomib to R-ICE Chemotherapy To Treat Relapsed/ Refractory Diffuse Large B-Cell Lymphoma
Status: Completed
Last Changed: Apr 27, 2017
First Received: Oct 22, 2010
Disease(s): Diffuse Large B-Cell Lymphoma
Intervention(s): bortezomib, rituximab, ifosphamide, etoposide, carboplatin
Locations: Singapore General Hospital, Singapore, Singapore
High-Dose Sequential Chemoimmunotherapy for B-Cell Lymphomas With Central Nervous System Involvement
Status: Unknown status
Last Changed: Dec 03, 2008
First Received: Dec 03, 2008
Disease(s): B-Cell Lymphomas
Intervention(s): High-dose sequential chemotherapy and autologous transplant
Locations: San Raffaele Scientific Institute, Milan, Italy
San Raffaele Scientific Institute, Milan, Italy
Trial of R-GemOx Versus R-miniCHOP Regimen in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma
Status: Recruiting
Last Changed: Jan 03, 2019
First Received: May 10, 2016
Disease(s): Diffuse Large B Cell Lymphoma
Intervention(s): Rituximab, Gemcitabine, Oxaliplatin, Cyclophosphamide, Epirubicin Injectable Product, Vindesine, Prednisone
Locations: Tongji Medical College of HUST, Wuhan, Hubei, China
The first Affiliated Hospital Of Nanjing Medical University(JiangSu Province Hospital), NanJing, Jiangsu, China
QiLu Hospital of Shandong University, Jinan, Shandong, China
Shandong Province Hospital, Jinan, Shandong, China
Rui Jin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
... and 2 other locations.
A Study Evaluating the Safety and Efficacy of Glofitamab or Mosunetuzumab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and High-Grade Large B-Cell Lymphoma
Status: Recruiting
Last Changed: Jul 23, 2020
First Received: Mar 18, 2020
Disease(s): B-cell Lymphoma
Intervention(s): Glofitamab, Gemcitabine, Oxaliplatin, Mosunetuzumab, Obinutuzumab, Tocilizumab
Locations: Prince of Wales Hospital; Haematology, Randwick, New South Wales, Australia
Monash Health Monash Medical Centre, Clayton, Victoria, Australia
St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia
High Dose, Absorbed Dose Adjusted 90Y-ibritumomab With Peripheral Blood Stem Cells (PBSC) Support in B-cell Lymphoma
Status: Completed
Last Changed: Feb 19, 2016
First Received: Sep 29, 2008
Disease(s): B-cell Lymphoma
Intervention(s): 90Y-ibritumomab
Locations: Lund University Hospital, Lund, Sweden
High-dose Chemotherapy With Rituximab for Adults With Aggressive Large B-cell Lymphoma
Status: Completed
Last Changed: Aug 26, 2009
First Received: Aug 25, 2009
Disease(s): B-Cell Lymphoma
Intervention(s): Rituximab
Locations: University Hospital, Nantes, France